AIMC Topic: Receptors, Thrombopoietin

Clear Filters Showing 1 to 1 of 1 articles

Could machine learning revolutionize how we treat immune thrombocytopenia?

British journal of haematology
The absence of reliable biomarkers in immune thrombocytopenia (ITP) complicates treatment choice, necessitating a trial-and-error approach. Machine learning (ML) holds promise for transforming ITP treatment by analysing complex data to identify predi...